View Future GrowthPyrophyte Acquisition 過去の業績過去 基準チェック /06Pyrophyte Acquisitionの収益は年平均-24.6%で減少しているが、Capital Markets業界はgrowingで6.3%年平均の収益となった。主要情報-24.63%収益成長率-63.56%EPS成長率Capital Markets 業界の成長10.26%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報30 Sep 2024最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • May 19Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/18/2026, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02Pyrophyte Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2026, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Dec 20Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 12/19/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 08/15/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/15/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Pyrophyte Acquisition Corp. announced delayed annual 10-K filingOn 03/31/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Oct 31NYSE to Commence Delisting Proceeding Against Pyrophyte Acquisition CorpThe New York Stock Exchange (“NYSE”, the “Exchange”) announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A Ordinary Shares, par value $0.0001 per share; Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant and Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (“Securities”) of Pyrophyte Acquisition Corp. (the “Company”) from the Exchange. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Sections 802.01B and 102.06e. of the NYSE’s Listed Company Manual because the Company failed to consummate a business combination within the shorter of (i) the time period specified by its constitutive documents or by contract or (ii) three years. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.お知らせ • Aug 15Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 08/14/2024, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 23Pyrophyte Acquisition Corp. Receives NYSE Notice Regarding Delayed Form 10-K FilingPyrophyte Acquisition Corp. (the “Company”) announced that it received a notice from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”) with the Securities and Exchange Commission (the “SEC”). The notice has no immediate effect on the listing of the Company’s securities on the NYSE. The NYSE informed the Company that, under the NYSE’s rules, the Company can regain compliance with the NYSE’s continued listing requirements by filing the 2023 Form 10-K with the SEC at any time prior to October 17, 2024. As the Company reported in its Form 12b-25 filed with the SEC on April 1, 2024, the Company requires additional time to complete its review of the 2023 Form 10-K and the financial statements included therein. The Company is working diligently to complete the 2023 Form 10-K and expects to file such report as soon as practicable.お知らせ • Apr 02Pyrophyte Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2024, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15+ 1 more updatePyrophyte Acquisition Corp. announced delayed 10-Q filingOn 11/14/2023, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/16/2023, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 06Pyrophyte Acquisition Corp. announced that it expects to receive $1.92 million in funding from Pyrophyte Acquisition LlcPyrophyte Acquisition Corp. announced a private placement of a convertible promissory note for gross proceeds of $1,920,000 on May 4, 2023. The transaction will include participation from returning investor Pyrophyte Acquisition Llc. The note will be issued at par. The note does not bear any interest and is repayable in full upon the earlier of the date of the consummation of its initial business combination, or the date of its liquidation. If the company does not consummate an initial business combination by the extended Date, the note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Upon maturity, the outstanding principal of the note may be converted into warrants, at a price of $1 per warrant, at the option of the investor. Such warrants will have terms identical to the warrants issued to the sponsor in a private placement that closed simultaneously with the company’s initial public offering. The company may receive the funds in multiple tranches.Board Change • Oct 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Per Pedersen was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Pyrophyte Acquisition の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:PHYU.F 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費30 Sep 24013030 Jun 24033031 Mar 24034031 Dec 23033030 Sep 23062030 Jun 23092031 Mar 230112031 Dec 220113030 Sep 220102030 Jun 22072031 Mar 220420質の高い収益: PHYU.Fには$4.6M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が30th September, 2024に影響を及ぼしています。利益率の向上: PHYU.Fの 利益率 が過去 1 年間で改善したかどうかを判断するにはデータが不十分です。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: PHYU.Fの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: PHYU.Fは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: PHYU.Fは過去 1 年間で収益成長率がマイナス ( -76.9% ) となったため、 Capital Markets業界平均 ( 38.3% ) と比較することが困難です。株主資本利益率高いROE: PHYU.Fの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YDiversified-financials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/07/11 23:15終値2025/04/14 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Pyrophyte Acquisition Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 19Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/18/2026, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02Pyrophyte Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2026, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Dec 20Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 12/19/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 08/15/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/15/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Pyrophyte Acquisition Corp. announced delayed annual 10-K filingOn 03/31/2025, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Oct 31NYSE to Commence Delisting Proceeding Against Pyrophyte Acquisition CorpThe New York Stock Exchange (“NYSE”, the “Exchange”) announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A Ordinary Shares, par value $0.0001 per share; Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant and Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (“Securities”) of Pyrophyte Acquisition Corp. (the “Company”) from the Exchange. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Sections 802.01B and 102.06e. of the NYSE’s Listed Company Manual because the Company failed to consummate a business combination within the shorter of (i) the time period specified by its constitutive documents or by contract or (ii) three years. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
お知らせ • Aug 15Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 08/14/2024, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 23Pyrophyte Acquisition Corp. Receives NYSE Notice Regarding Delayed Form 10-K FilingPyrophyte Acquisition Corp. (the “Company”) announced that it received a notice from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”) with the Securities and Exchange Commission (the “SEC”). The notice has no immediate effect on the listing of the Company’s securities on the NYSE. The NYSE informed the Company that, under the NYSE’s rules, the Company can regain compliance with the NYSE’s continued listing requirements by filing the 2023 Form 10-K with the SEC at any time prior to October 17, 2024. As the Company reported in its Form 12b-25 filed with the SEC on April 1, 2024, the Company requires additional time to complete its review of the 2023 Form 10-K and the financial statements included therein. The Company is working diligently to complete the 2023 Form 10-K and expects to file such report as soon as practicable.
お知らせ • Apr 02Pyrophyte Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2024, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15+ 1 more updatePyrophyte Acquisition Corp. announced delayed 10-Q filingOn 11/14/2023, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Pyrophyte Acquisition Corp. announced delayed 10-Q filingOn 05/16/2023, Pyrophyte Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 06Pyrophyte Acquisition Corp. announced that it expects to receive $1.92 million in funding from Pyrophyte Acquisition LlcPyrophyte Acquisition Corp. announced a private placement of a convertible promissory note for gross proceeds of $1,920,000 on May 4, 2023. The transaction will include participation from returning investor Pyrophyte Acquisition Llc. The note will be issued at par. The note does not bear any interest and is repayable in full upon the earlier of the date of the consummation of its initial business combination, or the date of its liquidation. If the company does not consummate an initial business combination by the extended Date, the note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Upon maturity, the outstanding principal of the note may be converted into warrants, at a price of $1 per warrant, at the option of the investor. Such warrants will have terms identical to the warrants issued to the sponsor in a private placement that closed simultaneously with the company’s initial public offering. The company may receive the funds in multiple tranches.
Board Change • Oct 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Per Pedersen was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.